MLICM
AGIO icon

Metropolitan Life Insurance Company (MetLife)’s Agios Pharmaceuticals AGIO Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,956
Closed -$86.4K – 66
2024
Q1 		$86.4K Sell
2,956
-417
-12% -$11.2K ﹤0.01% 1129
2023
Q4 		$75.1K Hold
3,373
– – ﹤0.01% 1233
2023
Q3 		$83.5K Buy
3,373
+272
+9% +$7.2K ﹤0.01% 1111
2023
Q2 		$87.8K Hold
3,101
– – ﹤0.01% 1082
2023
Q1 		$71.2K Sell
3,101
-271
-8% -$7.2K ﹤0.01% 1184
2022
Q4 		$94.7K Hold
3,372
– – ﹤0.01% 1076
2022
Q3 		$95.4K Hold
3,372
– – ﹤0.01% 1045
2022
Q2 		$74.8K Hold
3,372
– – ﹤0.01% 1241
2022
Q1 		$98.2K Sell
3,372
-12,193
-78% -$373K ﹤0.01% 1203
2021
Q4 		$512K Hold
15,565
– – 0.01% 1405
2021
Q3 		$718K Sell
15,565
-1,366
-8% -$66K 0.01% 1195
2021
Q2 		$933K Buy
16,931
+15,379
+991% +$860K 0.01% 1066
2021
Q1 		$80.1K Buy
1,552
+24
+2% +$1.19K ﹤0.01% 2474
2020
Q4 		$66.2K Sell
1,528
-42
-3% -$1.66K ﹤0.01% 2450
2020
Q3 		$55K Sell
1,570
-28
-2% -$1.23K ﹤0.01% 2460
2020
Q2 		$85.5K Sell
1,598
-152
-9% -$7.04K ﹤0.01% 2348
2020
Q1 		$62.1K Sell
1,750
-14
-0.8% -$647 ﹤0.01% 2310
2019
Q4 		$84.2K Buy
1,764
+245
+16% +$9.26K ﹤0.01% 2419
2019
Q3 		$49.2K Sell
1,519
-2,045
-57% -$84.7K ﹤0.01% 2499
2019
Q2 		$178K Sell
3,564
-80
-2% -$4.28K ﹤0.01% 1965
2019
Q1 		$246K Sell
3,644
-76
-2% -$4.43K ﹤0.01% 1764
2018
Q4 		$172K Sell
3,720
-12
-0.3% -$741 ﹤0.01% 1923
2018
Q3 		$288K Sell
3,732
-81
-2% -$6.52K ﹤0.01% 1740
2018
Q2 		$321K Buy
3,813
+294
+8% +$25.6K 0.01% 1607
2018
Q1 		$288K Buy
3,519
+562
+19% +$43.4K ﹤0.01% 1644
2017
Q4 		$169K Sell
2,957
-32
-1% -$2.01K ﹤0.01% 2006
2017
Q3 		$200K Buy
2,989
+157
+6% +$9.43K ﹤0.01% 2273
2017
Q2 		$146K Buy
2,832
+705
+33% +$36K ﹤0.01% 2477
2017
Q1 		$124K Hold
2,127
– – ﹤0.01% 2421
2016
Q4 		$89K Buy
2,127
+91
+4% +$4.78K ﹤0.01% 2548
2016
Q3 		$108K Sell
2,036
-98
-5% -$4.27K ﹤0.01% 2544
2016
Q2 		$89K Buy
2,134
+197
+10% +$9.73K ﹤0.01% 2605
2016
Q1 		$79K Hold
1,937
– – ﹤0.01% 2435
2015
Q4 		$126K Buy
1,937
+52
+3% +$3.41K ﹤0.01% 2481
2015
Q3 		$133K Hold
1,885
– – ﹤0.01% 2524
2015
Q2 		$209K Sell
1,885
-9,491
-83% -$1.02M ﹤0.01% 2370
2015
Q1 		$1.07M Buy
11,376
+396
+4% +$44.4K 0.01% 1166
2014
Q4 		$1.23M Buy
10,980
+281
+3% +$25.1K 0.01% 1202
2014
Q3 		$656K Hold
10,699
– – ﹤0.01% 1537
2014
Q2 		$490K Buy
10,699
+4,465
+72% +$182K ﹤0.01% 1839
2014
Q1 		$244K Buy
+6,234
New +$209K ﹤0.01% 2322
2013
Q4 		– Sell
-8,019
Closed -$224K – 2738
2013
Q3 		$224K Buy
+8,019
New +$221K ﹤0.01% 2335

Other funds holding AGIO

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s AGIO Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Agios Pharmaceuticals (AGIO) in Q2 2024, closing a stake of 2,956 shares — an estimated $86.4K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in AGIO in Q3 2013 and held it in 42 quarters. The position peaked at $1.23M in Q4 2014. 206 funds tracked by Wall St. Rank hold AGIO as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Agios Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 2,956 Agios Pharmaceuticals shares in Q2 2024, an estimated $86.4K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Agios Pharmaceuticals in Q3 2013 and held it in 42 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Agios Pharmaceuticals position peaked at $1.23M in Q4 2014.
  • 206 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.